After the onset of stroke, HSP70 is rapidly upregulated in response to various pathological processes. It regulates the pathological process of stroke mainly by mediating cell death and inflammatory responses. However, more mechanisms of action are not yet clear. Even the results of some studies show that HSP70 has no protective effect in transgenic stroke mouse models. Given the ambiguity and inconsistency of the current results on HSP70, Ace Therapeutics provides a comprehensive and rigorous service to explore the role of HSP70 in the stroke process.
HSP70 can regulate a variety of cell death-related signaling pathways, including the intrinsic apoptotic pathway mediated by Bcl-2 family proteins and the extrinsic apoptotic pathway mediated by cell surface receptors. To address the role of HSP70 in cell death signaling pathways, we provide different stroke models and a well-established assay service.
Neuroinflammation is a key feature of acute nerve injury and an important pathological activity in stroke. Studies have proved that in the pathological process of stroke, HSP70 can enhance the immune response outside the cell and regulate the inflammatory response inside the cell, but how to regulate the inflammatory response is still unclear. Ace Therapeutics provides a series of services to explore the role of HSP70 in the regulation of inflammatory response in the pathological process of stroke.
Ace Therapeutics provides a one-stop scientific service to explore the role of HSP70 in stroke in a scientific and accurate manner. If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.